•The New England Journal of Medicine published full results of the Phase 3 TETON-2 study evaluating nebulized Tyvaso.
•The study met its primary efficacy endpoint, with nebulized Tyvaso demonstrating statistically significant improvement in absolute forced vital capacity for IPF patients.
•The International Energy Agency announced that its 32 member countries will make 400 million barrels of emergency oil reserves available to the market.
•Marathon Petroleum Corp (MPC) shares traded higher on Wednesday following the announcement.
